rs6997709 — KCNK9

KCNK9 8q24 Variant — Adrenal Potassium Channel Tone and Blood Pressure

The KCNK9 gene encodes TASK3, a two-pore domain background potassium channel¹¹ two-pore domain background potassium channel
K2P channel: always-open K⁺ leak channels that set the resting membrane potential of excitable and secretory cells that is highly expressed in the adrenal zona glomerulosa — the thin outer layer of the adrenal cortex responsible for producing aldosterone. Aldosterone is the steroid hormone that tells the kidneys to retain sodium and water, raising blood volume and therefore blood pressure. When TASK3 channel activity is reduced, zona glomerulosa cells depolarize, increasing calcium influx and stimulating excess aldosterone synthesis. rs6997709 sits approximately 433 kilobases upstream of KCNK9 in an intergenic region that may influence KCNK9 expression through long-range regulatory elements, and its T allele was flagged as a suggestive hypertension signal in the landmark 2007 Wellcome Trust Case Control Consortium (WTCCC) genome-wide association study.

The Mechanism

TASK3 (KCNK9) and its close relative TASK1 (KCNK3) together produce the background K⁺ conductance that sets the resting membrane potential of adrenal glomerulosa cells. Bandulik et al. 2010²² Bandulik et al. 2010
Bandulik S et al. TASK1 and TASK3 potassium channels: determinants of aldosterone secretion and adrenocortical zonation. Horm Metab Res 2010 showed that these channels are molecular targets of angiotensin II signalling: when angiotensin II binds its receptor, it closes these channels, depolarizes the membrane, and opens voltage-gated calcium channels to drive aldosterone secretion. Genetically reducing this channel tone — as in Kcnk9-knockout mice — produces autonomous aldosterone excess and elevated blood pressure even without elevated renin.

rs6997709 is an intergenic regulatory variant; it does not change the TASK3 protein itself. Its position ~433 kb upstream of KCNK9 places it in a region that may harbour enhancer elements with long-range chromatin contacts to the KCNK9 promoter. The T allele may reduce TASK3 expression, tilting the zona glomerulosa toward a more depolarized resting state and enhanced aldosterone responsiveness.

The Evidence

The WTCCC 2007 genome-wide association study³³ WTCCC 2007 genome-wide association study
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007 identified rs6997709 as a suggestive hypertension signal in a British population (n ~2,000 hypertensive cases, ~3,000 controls). A Korean replication study (Hong et al. 2009)⁴⁴ Korean replication study (Hong et al. 2009)
Hong KW et al. Replication of the WTCCC genome-wide association study on essential hypertension in a Korean population. Hypertens Res 2009 found rs6997709 associated with systolic blood pressure in a continuous trait analysis, though it did not reach case-control significance, consistent with a modest additive effect on BP rather than a binary hypertension switch.

Mechanistic support comes from a study by Jung et al. 2012⁵⁵ Jung et al. 2012
Jung J et al. Variations in the potassium channel genes KCNK3 and KCNK9 in relation to blood pressure and aldosterone production. J Clin Endocrinol Metab 2012 that examined 74 KCNK9 SNPs in 795 participants: multiple KCNK9 variants associated with systolic blood pressure in African Americans and with aldosterone production indices in both European and African Americans, placing the KCNK9 locus within the aldosterone pathway that links potassium channel genetics to blood pressure.

A 2025 nutrigenetics scoping review Holzbach et al. 2025⁶⁶ Holzbach et al. 2025
Holzbach LC et al. Nutrigenetics and Nutritional Strategies in Systemic Arterial Hypertension. Nutr Rev 2025 identified rs6997709 among 13 SNPs with documented interactions with dietary sodium intake and blood pressure, consistent with an aldosterone-mediated salt-sensitivity mechanism.

The evidence level is moderate: the original GWAS signal was suggestive rather than genome-wide significant, and the biological mechanism (regulatory effect on KCNK9 expression) has not yet been confirmed by eQTL studies at this specific locus.

Practical Actions

For T-allele carriers, the most relevant lever is dietary sodium. If the KCNK9 locus reduces aldosterone-suppressing channel tone, then high sodium intake may be more pressor for T carriers than for GG individuals. Specifically:

• Restrict dietary sodium to below 2,000 mg/day (roughly 5 g salt), a threshold that clinical guidelines already recommend for hypertension management but that carries extra weight here given the gene-sodium interaction evidence.
• Monitor blood pressure proactively — home blood pressure monitoring provides higher-resolution data than clinic visits and can detect masked or white-coat hypertension.
• Monitor aldosterone-to-renin ratio (ARR) if blood pressure is consistently elevated despite dietary intervention, as the mechanistic model predicts aldosterone-driven low-renin hypertension rather than classical renin-dependent hypertension.

Interactions

The strongest compound interaction partner is GNB3 rs5443, which also showed sodium-interaction in the same scoping review and is a well-established modulator of blood pressure in salt-sensitive populations. ACE rs4646994 and NOS3 rs2070744 interact with the same aldosterone-renin-angiotensin axis; individuals carrying risk variants at multiple loci in this pathway may have additive hypertension susceptibility.

Within the KCNK9 gene itself, rs888345 is the KCNK9 intronic variant most strongly associated with blood pressure in African Americans and with aldosterone production indices in both Europeans and African Americans; it may be in partial linkage disequilibrium with rs6997709 in some populations.